XKRX
001685
Market cap523mUSD
Jul 10, Last price
14,260.00KRW
1D
0.78%
1Q
-13.58%
Jan 2017
10.97%
Name
Daesang Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in Seoul, South Korea, in 1956, Daesang Corporation operates globally, producing and distributing a wide array of food products and specialized ingredients. Its consumer-facing offerings include general foodstuffs like traditional bean pastes and seasonings, agro-fishery items such as vinegar and fish sauce, and fresh selections like Kimchi, tofu, western meals, deli items, and frozen foods. Beyond the consumer market, Daesang is a significant supplier of food ingredients; this includes various starches used in food, paper, textile, and construction industries, along with sweeteners critical for alcoholic beverages, confectionery, baking, and other drink sectors. The company also develops advanced bio ingredients, such as flavor enhancers, amino acids, and microalgae-based products, which are vital for food, dietary supplements, functional foods, animal nutrition, pet food, and pharmaceutical applications. Its Miwon brand bio ingredients are exported to approximately 80 countries worldwide. Additionally, Daesang is actively involved in the food distribution business.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||